BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 32152775)

  • 1. International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
    Teras J; Kroon HM; Miura JT; Kenyon-Smith T; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Potdar A; Daou H; Sun J; Carr M; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Barbour A; Tyler DS; Coventry BJ; Zager JS; Thompson JF
    Ann Surg Oncol; 2020 May; 27(5):1420-1429. PubMed ID: 32152775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.
    Kenyon-Smith TJ; Kroon HM; Miura JT; Teras J; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Barbour A; Coventry BJ; Tyler DS; Zager JS; Thompson JF
    Eur J Surg Oncol; 2020 Nov; 46(11):2140-2146. PubMed ID: 32739218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
    Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF
    Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.
    Dossett LA; Ben-Shabat I; Olofsson Bagge R; Zager JS
    Ann Surg Oncol; 2016 Jul; 23(7):2330-5. PubMed ID: 26926481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
    Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Mark Smithers B; Coventry BJ; Tyler DS; Thompson JF; Zager JS
    Ann Surg Oncol; 2019 Aug; 26(8):2486-2494. PubMed ID: 30911949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study.
    Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Smithers BM; Thompson JF
    Ann Surg Oncol; 2017 Oct; 24(11):3245-3251. PubMed ID: 28799064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era?
    Teras J; Kroon HM; Thompson JF; Teras M; Pata P; Mägi A; Teras RM; Boudinot SR
    Eur J Surg Oncol; 2020 Feb; 46(2):272-276. PubMed ID: 31748147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.
    Li S; Sheng X; Si L; Cui C; Kong Y; Mao L; Lian B; Tang B; Yan X; Wang X; Chi Z; Guo J
    Ann Surg Oncol; 2018 Apr; 25(4):885-893. PubMed ID: 29270879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.
    Madu MF; Deken MM; van der Hage JA; Jóźwiak K; Wouters MWJM; van Akkooi ACJ
    Ann Surg Oncol; 2017 Jul; 24(7):1997-2005. PubMed ID: 28188500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions.
    O'Donoghue C; Perez MC; Mullinax JE; Hardman D; Sileno S; Naqvi SMH; Kim Y; Gonzalez RJ; Zager JS
    Ann Surg Oncol; 2017 Dec; 24(13):3842-3849. PubMed ID: 29019175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.
    Beasley GM; Sharma K; Wong J; Miller M; Turley RS; Lidsky M; Masoud M; Dewhirst MW; Mosca PJ; Zager JS; Tyler DS
    Cancer; 2012 Dec; 118(24):6136-43. PubMed ID: 22674423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia.
    Carr MJ; Sun J; Kroon HM; Miura JT; Beasley GM; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH; Kirichenko DA; Potdar A; Daou H; Mullen D; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Coventry BJ; Tyler DS; Thompson JF; Zager JS
    Ann Surg Oncol; 2020 Dec; 27(13):5107-5118. PubMed ID: 32918177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Bagge AS; Ben-Shabat I; Belgrano V; Olofsson Bagge R
    Ann Surg Oncol; 2016 Jun; 23(6):2062-9. PubMed ID: 26868956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing in management of in-transit melanoma metastasis: Diphencyprone versus isolate limb infusion.
    Lo MC; Garioch J; Moncrieff MD
    J Plast Reconstr Aesthet Surg; 2020 Jul; 73(7):1263-1267. PubMed ID: 32245735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study.
    Read T; Fayers W; Thomas J; Wagels M; Barbour A; Mark Smithers B
    J Surg Oncol; 2019 May; 119(6):717-727. PubMed ID: 30644564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma.
    Mullinax JE; Kroon HM; Thompson JF; Nath N; Mosca PJ; Farma JM; Bhati R; Hardmann D; Sileno S; O'Donoghue C; Perez M; Naqvi SM; Chen YA; Gonzalez RJ; Zager JS
    J Am Coll Surg; 2017 Apr; 224(4):635-642. PubMed ID: 28214556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies.
    Smith HG; Wilkinson MJ; Smith MJF; Strauss DC; Hayes AJ
    Eur J Cancer; 2018 Sep; 100():46-54. PubMed ID: 29940423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated limb infusion: Institutional protocol and implementation.
    Carr MJ; Sun J; Zager JS
    J Surg Oncol; 2020 Jul; 122(1):99-105. PubMed ID: 32162353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis.
    Ma Q; Zhao Z; Barber BL; Shilkrut M
    Adv Ther; 2016 Feb; 33(2):282-9. PubMed ID: 26797898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoglobin does not predict local toxicity in isolated limb perfusion.
    Nyström Wendt A; Mattsson J; Olofsson Bagge R
    Int J Hyperthermia; 2017 Sep; 33(6):679-683. PubMed ID: 28540796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.